Trends in alcohol withdrawal management by medical toxicologists in the acute care setting: an analysis of the Toxicology Investigators Consortium (ToxIC) Core Registry, 2016–2022
Use of benzodiazepines alone to manage AWS decreased while phenobarbital, ketamine, and dexmedetomidine use increased. Many patients had severe withdrawal manifestations, and some received alcohol use disorder treatment, suggesting that medical toxicologists see more severe cases in the acute care setting and have an opportunity to address the underlying use disorder.
Authors
- Alison Sutter (ORCID: https://orcid.org/0000-0001-5289-9984)
- Hope Kincaid (ORCID: https://orcid.org/0000-0002-1087-1067)
- Kathryn L Wheel
- Ryan Surmaitis
- Kira Galeano
- Gillian A. Beauchamp (ORCID: https://orcid.org/0000-0002-4758-8695)
- Alexandra Amaducci
- Joseph J Stirparo
- John D DelBianco
- Stephanie E. Shara
Institutions
- Lehigh Valley Hospital-Pocono (US)
- Lehigh Valley Health Network (US)
Publication Details
- Journal
- Alcohol and Alcoholism
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1093/alcalc/agaf047
- Citations
- 1
- Primary Topic
- Alcoholism and Thiamine Deficiency
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Centers for Disease Control and Prevention
- U.S. Food and Drug Administration